ASKA Pharmaceutical Holdings Co.,Ltd.(4886) Summary
4886
TSE Prime
ASKA Pharmaceutical Holdings Co.,Ltd.
Result
2,111
JPY
+20
(+0.96%)
Aug 14, 3:30 pm JST
13.25
USD
Aug 14, 2:30 am EDT
PER
12.5
PBR
0.85
Yield
3.08%
Margin Trading Ratio
153.00
PTS
outside of trading hours
ー
ー
Stock Price
Aug 14, 2026
Opening
Aug 14, 9:00 am
2,063
JPY
12.93
USD
Previous Close
Aug 13
2,091
JPY
13.11
USD
High
Aug 14, 2:02 pm
2,114
JPY
13.26
USD
Low
Aug 14, 9:00 am
2,063
JPY
12.93
USD
Volume
57,800
Trading Value
0.12B
JPY
0.76M
USD
VWAP
2096.64
JPY
13.16
USD
Minimum Trading Value
211,100
JPY
1,325
USD
Market Capitalization
0.06T
JPY
0.38B
USD
Number of Trades
292
Opening
ー
ー
JPY
Previous Close
Aug 14
2,105.1
JPY
High
ー
ー
JPY
Low
ー
ー
JPY
Volume
ー
Trading Value
ー
JPY
VWAP
ー
JPY
Minimum Trading Value
ー
Market Capitalization
ー
Number of Trades
ー
PTS Stock Price
Liquidity & Number of Trades
As of Aug 14, 2026
Liquidity
Liquidity Grade
| Liquidity | Number Of Trades | Distribution |
|---|---|---|
| High | Over 1,000 | 13.9% |
| Slightly-High | 400 to 1,000 | 18.5% |
| Mid | 50 to 400 | 39.0% |
| Slightly-Low | 10 to 50 | 17.6% |
| Low | Less than 10 | 11.0% |
Slightly High
1-Year Average
456
1-Year High
Jan 29, 2026
3,529
Margin Trading
| Date | Short Interest | Long Margin Positions | Ratio |
|---|---|---|---|
| Aug 7, 2026 | 800 | 122,400 | 153.00 |
| Jul 31, 2026 | 500 | 114,100 | 228.20 |
| Jul 24, 2026 | 500 | 178,100 | 356.20 |
| Jul 17, 2026 | 500 | 192,100 | 384.20 |
| Jul 10, 2026 | 500 | 192,900 | 385.80 |
Company Profile
ASKA Pharmaceutical Holdings Co., Ltd. specializes in gynecology and urology, with hormone preparations as its main products. The company sells generic drugs for Takeda and also develops new drugs.
Sector
Pharmaceuticals
ASKA Pharmaceutical Holdings Co., Ltd. focuses on the pharmaceutical business as its core, while also operating in animal health and clinical testing sectors. In the pharmaceutical business, "Aska Pharmaceutical" specializes in products for internal medicine, obstetrics and gynecology, and urology, which are distributed through Takeda Pharmaceutical Company. The animal health business is managed by "Aska Animal Health," which procures some products from Aska Pharmaceutical while also outsourcing manufacturing to Aska Pharmaceutical. The clinical testing business is operated by "Aska Pharmaceutical Medical," which leases facilities from Aska Pharmaceutical for its operations. Additionally, Aska Pharmaceutical handles the procurement and sales of medical devices and health foods. The company has adopted a holding company structure to manage its group companies effectively.